Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions

Retrospective chart review to determine the presence of rhabdomyolysis among patients admitted to CHMCA from 1997-2007 with Jimsonweed ingestions and to define possible risk factors predisposing patients to the developement of Jimsonweed-associated rhabdomyolysis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Rhabdomyolysis Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Hemoglobinuria Male Urogenital Diseases Muscular Diseases Musculoskeletal Diseases Myoglobinuria Pathological Conditions, Signs and Symptoms Proteinuria Signs and Symptoms Urination Disorders Urogenital Diseases Urologic Diseases Urological Manifestations

Age range

Up to 21 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Children's Hospital Medical Center of Akron

Akron, Ohio, 44308, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

admitted to CHMCA between 1/1/1997 to 12/31/2007 with a qualifying ICD-9 diagnosis code for rhabdomyolysis, myoglobinuria, and hemoglobinuria (728.88, 791.2, 791.3)or other ICD-9 codes identified during the study
between the ages of 0-21 years at diagnosis

Exclusion criteria

rhabdomyolysis or serum CK concentrations not actually documented
patient admitted to the burn center
patient > 21 years of age

Treatment and study plan

Primary outcomes

The presence of rhabdomyolysis based on serum CK concentrations in patients admitted with history of Jimsonweed ingestion.

Time frame: From admission until discharge

Secondary outcomes

Renal function, liver function, vital signs, physical exam

Time frame: From admission until discharge

Sponsors and collaborators

Lead sponsor

Akron Children's Hospital

Other

Registry information

Official study title

Incidence of Rhabdomyolysis Among Pediatric and Adolescent Patients Admitted for Jimsonweed (Datura Stramonium) Ingestions

Important dates

Study start: 2008
Primary completion: 2008
Study completion: 2008
First posted: Jan 14, 2008
Registry last updated: Jul 28, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed